Todos os posts

Estudo de coorte | Risco de fratura de quadril entre pessoas que consomem carne, que só consomem peixes e em vegetarianos.

12 Ago, 2022 | 18:06h

Risk of hip fracture in meat-eaters, pescatarians, and vegetarians: results from the UK Women’s Cohort Study – BMC Medicine

Comunicado de imprensa: Vegetarian women are at a higher risk of hip fracture – University of Leeds

 

---

Diretriz de consenso | Tratamento farmacológico da rinite alérgica.

12 Ago, 2022 | 18:04h

Pharmacological Management of Allergic Rhinitis: A Consensus Statement from the Malaysian Society of Allergy and Immunology – Journal of Asthma and Allergy

Conteúdos relacionados:

Pharmacologic Treatment of Seasonal Allergic Rhinitis: Synopsis of Guidance From the 2017 Joint Task Force on Practice Parameters – Annals of Internal Medicine

Chinese Society of Allergy Guidelines for Diagnosis and Treatment of Allergic Rhinitis – Allergy Asthma & Immunology Research

 

---

Estudo randomizado | Efeito de dexmedetomidina versus midazolam intranasal para pré-medicação em casos de eventos adversos respiratórios em crianças submetidas a tonsilectomia e adenoidectomia.

12 Ago, 2022 | 18:02h

Effect of Intranasal Dexmedetomidine or Midazolam for Premedication on the Occurrence of Respiratory Adverse Events in Children Undergoing Tonsillectomy and Adenoidectomy: A Randomized Clinical Trial – JAMA Network Open

Comentários:

Perioperative Respiratory Adverse Events After Pediatric Adenotonsillectomy—Evaluating the Role of Preoperative Pharmacologic Anxiolysis – JAMA Network Open

Dexmedetomidine Cuts Perioperative Respiratory AEs in Tonsillectomy – HealthDay

 

Comentário no Twitter

Children often required sedatives before surgery due to anxiety and crying. In this RCT, intranasal midazolam increased the incidence of perioperative respiratory adverse events (PRAEs), while intranasal dexmedetomidine reduced PRAEs. #OrigInvestigation https://t.co/5AAILuzstM pic.twitter.com/WejpGkAGGs

— JAMA Network Open (@JAMANetworkOpen) August 9, 2022

 

---

Estudo randomizado | Efeito da acupuntura adjunta no alívio da dor em pacientes de departamentos de emergência com cólica renal aguda decorrente de nefrolitíase.

12 Ago, 2022 | 18:00h

Effect of Adjunctive Acupuncture on Pain Relief Among Emergency Department Patients With Acute Renal Colic Due to Urolithiasis: A Randomized Clinical Trial – JAMA Network Open

Comentário: Adjunctive Acupuncture May Speed Relief From Pain of Renal Colic – HealthDay

 

Comentário no Twitter

In this #RCT of emergency department patients with renal colic who received IM NSAIDs, acupuncture provided additional fast short-term pain relief for compared with sham acupuncture. #OrigInvestigation https://t.co/7i2wk86hif pic.twitter.com/VHNDFqOcOx

— JAMA Network Open (@JAMANetworkOpen) August 9, 2022

 

---

Estudo randomizado | Decitabina em baixa dose vs. azacitidina em baixa dose nas síndromes mielodisplásicas de baixo risco.

12 Ago, 2022 | 17:58h

Low-Dose Decitabine versus Low-Dose Azacitidine in Lower-Risk MDS – NEJM Evidence

 

Comentário no Twitter

Low dose hypomethylating agent therapy led to an overall response rate of 60% in pts with low- or intermediate-risk myelodysplastic syndromes or chronic myelomonocytic leukemia who had not received prior hypomethylating agents. https://t.co/OSpNLzfiKW#MDS #LeuSM #CMML pic.twitter.com/BN1XAhfUBo

— NEJM Evidence (@NEJMEvidence) August 9, 2022

 

---

Remoção extracorpórea de dióxido de carbono para insuficiência respiratória aguda: revisão de potenciais indicações, prática clínica e questões para pesquisas.

12 Ago, 2022 | 17:57h

Extracorporeal carbon dioxide removal for acute respiratory failure: a review of potential indications, clinical practice and open research questions – Intensive Care Medicine

 

Comentário no Twitter

Extracorporeal carbon dioxide removal #ECCO2r: to date indications & risk-to-beneft ratio of this technique should now be carefully evaluated using structured national or international registries and large randomized trials. Here #FOAMcc narrative review
🖇️https://t.co/CN8OSha8uY https://t.co/zEFBMAF9dW pic.twitter.com/QqPG00QKPU

— Intensive Care Medicine (@yourICM) August 10, 2022

 

---

Revisão sistemática | Antibióticos inalados para exacerbações pulmonares na fibrose cística.

12 Ago, 2022 | 17:55h

Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis – Cochrane Library

Resumo: Inhaling antibiotics to treat temporary worsening of lung infection in people with cystic fibrosis – Cochrane Library

 

---

Estudo randomizado | Tratamento tópico do edema macular diabético com uso de suspensão oftálmica de dexametasona.

12 Ago, 2022 | 17:54h

Topical treatment of diabetic macular edema using dexamethasone ophthalmic suspension: A randomized, double-masked, vehicle-controlled study – Acta Ophthalmologica

Comentário: Topical Dexamethasone Ophthalmic Suspension OCS-01 Effective in DME Treatment – HCP Live

 

---

Estudo de coorte | Associação entre agonistas do hormônio liberador de gonadotropina para câncer de próstata e risco de doença cardiovascular e hipertensão em homens diabéticos.

12 Ago, 2022 | 17:53h

Association of Gonadotropin-Releasing Hormone Agonists for Prostate Cancer With Cardiovascular Disease Risk and Hypertension in Men With Diabetes – JAMA Network Open

 

Comentário no Twitter

Study showed men with #T2DM on GnRH for prostate cancer had a 53% higher risk of an increase in CVD risk score than those not on GnRH, suggesting the need to control cardiovascular disease risk factors in men with T2DM receiving GnRH. #OrigInvestigation https://t.co/3cJ10PpQGN

— JAMA Network Open (@JAMANetworkOpen) August 8, 2022

 

---

Estudo de centro único fase 2 | Durvalumabe com tremelimumabe em sarcomas ósseos e de tecido mole avançados ou metastáticos.

12 Ago, 2022 | 17:51h

Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial – The Lancet Oncology (link para o resumo – $ para o texto completo)

 

Comentário no Twitter

Online first: #Durvalumab plus #tremelimumab in advanced or metastatic soft tissue and bone #sarcomas: a single-centre phase 2 trial https://t.co/Zt9vTFzBOK pic.twitter.com/BP7fz9FWRw

— The Lancet Oncology (@TheLancetOncol) August 5, 2022

 

---